Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
---|---|---|---|---|---|---|
STOK | Stoke Therapeutics, Inc. | General Counsel & Corp Sec | $418K | -$211K | -33.6% | May 20, 2024 |
Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
---|